Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cg Oncology Inc (CGON)

Cg Oncology Inc (CGON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,171,131
  • Shares Outstanding, K 66,640
  • Annual Sales, $ 200 K
  • Annual Income, $ -48,610 K
  • 60-Month Beta N/A
  • Price/Sales 11,201.40
  • Price/Cash Flow N/A
  • Price/Book 4.02
Trade CGON with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.36
  • Most Recent Earnings $-0.36 on 05/09/24
  • Next Earnings Date 06/25/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 95.35% ( +3.68%)
  • Historical Volatility 90.41%
  • IV Percentile 28%
  • IV Rank 61.28%
  • IV High 154.72% on 05/02/24
  • IV Low 1.40% on 03/13/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 47
  • Put/Call OI Ratio 2.62
  • Today's Open Interest 355
  • Open Int (30-Day) 663

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.42
  • Number of Estimates 3
  • High Estimate -0.34
  • Low Estimate -0.53
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.77 +26.43%
on 05/13/24
46.99 -30.67%
on 05/03/24
-7.61 (-18.94%)
since 04/30/24
3-Month
25.77 +26.43%
on 05/13/24
46.99 -30.67%
on 05/03/24
-12.13 (-27.13%)
since 02/29/24

Most Recent Stories

More News
Everyone's Talking About These 2 Biotech IPO Stocks, But Are They Buys?

The market's excited for these stocks, but there's no rush to buy them.

KYTX : 12.53 (+1.70%)
CGON : 32.58 (-4.99%)

Business Summary

CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology is based in IRVINE, Calif.

See More

Key Turning Points

3rd Resistance Point 36.66
2nd Resistance Point 35.53
1st Resistance Point 34.06
Last Price 32.58
1st Support Level 31.46
2nd Support Level 30.33
3rd Support Level 28.86

See More

52-Week High 50.23
Fibonacci 61.8% 40.89
Fibonacci 50% 38.00
Fibonacci 38.2% 35.11
Last Price 32.58
52-Week Low 25.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar